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Primary ciliary dyskinesia (PCD) is usually inherited as an
autosomal recessive disorder and presents with upper and
lower respiratory tract infection, and mirror image arrangement
in around 50% of cases. Cilia dysfunction is also implicated in a
wider spectrum of disease, including polycystic liver and kidney
disease, central nervous system problems including retinopathy
and hydrocephalus, and biliary atresia. Cilia are complex
structures, containing more than 250 proteins; recent studies
have begun to locate PCD genes scattered throughout the
genome. Screening tests for PCD include nasal nitric oxide and
in vivo tests of ciliary motility such as the saccharin test. Specific
diagnosis requires examination of cilia by light and electron
microscopy, with epithelial culture in doubtful cases. This is only
available in supra-regional centres, recently centrally funded by
the National Commissioning Group. Treatment is not evidence
based and recommendations are largely extrapolated from
cystic fibrosis and other suppurative lung diseases.
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rimary ciliary dyskinesia (PCD) is usually an
autosomal recessive disease characterised by
chronic upper and lower respiratory tract
infection, and in nearly 50% cases, mirror image
arrangement.1 The triad of mirror image arrange-
ment, bronchiectasis and sinusitis is known as
Kartagener syndrome. It is caused by a congenital
reduction or absence of ciliary function. PCD must
be distinguished from the numerous causes of
secondary ciliary dysfunction. PCD is often diag-
nosed late,2 after a period of chronic ill health. Cilia
are also implicated in polycystic hepatic and renal
disease, hydrocephalus, biliary atresia, retinal
degeneration and rare syndromes.2 3 Motile nodal
cilia are responsible for normal right-left orienta-
tion, but there may be other important develop-
mental roles elsewhere in the embryo.3 4 This
article provides an update on PCD, which is
particularly timely as it coincides with the devel-
opment of a diagnostic screening service for PCD
in England. The National Commissioning Group
(NCG) is funding centres in London, Leicester and
Southampton to utilise state of the art diagnostic
methods to increase the numbers of patients
diagnosed. Since the test is centrally funded, the
referring centre incurs no costs. Early diagnosis of
PCD is likely to have a significant effect on both
short-term and long-term morbidity,5 6 although
this cannot be proven by any practical study. The
development of proper diagnostic services will also
lead to the establishment of a national registry,
which should facilitate the performance of rando-
mised controlled trials.
BIOPHYSICS OF CILIA
Over 250 proteins make up the classical ciliary
axoneme that forms a ‘‘9+2’’ arrangement where
nine peripheral doublets surround the central
microtubular pair7 (fig 1). The ATPase activity of
the dynein arms generates the force required for
ciliary beating and bending. Situs inversus is seen
in up to 50% of patients with PCD due to abnormal
movement of nodal cilia during embryogenesis.
GENETICS
PCD has an estimated prevalence of 1:15–30 000
live births, although this is likely be an under-
estimate as underdiagnosis is common.1 PCD is
usually an autosomal recessive disorder, however
occasional instances of X-linked transmission have
been reported.7 8 The molecular complexity of the
axonemes of cilia and sperm means that there are
a large number of potential candidate genes. PCD
is genetically heterogeneous, being caused by
mutations in a number of different genes.9–11 So
far two genes encoding dyneins have been
confirmed to cause PCD. The DNAH5 gene located
on chromosome 5p15.2 encodes a heavy chain
dynein and the DNAI1 gene on 9p13.3 encodes a
dynein intermediate chain. Two additional dyneins
have been associated with PCD. Homozygous
mutations in the DNAH11 gene on chromosome
7, which encodes an axonemal heavy chain, were
determined in an individual with situs inversus
but no apparent ciliary ultrastructural defects.12
Proteomic studies have also implicated DNAH7,
another dynein heavy chain. In ciliated epithelial
cells from an individual with PCD and an ultra-
structural defect of absent inner arms, the DNAH7
protein was found to be expressed but not
assembled into the cilia. No mutations in the
DNAH7 gene were detected, so the possibility that
this may be an indirect effect arising from
mutations in another gene could not be excluded.9
Genetic linkage studies have found significant
evidence for several other PCD loci, notably those
on chromosomes 15q13–15, 15q24–q25, 16p and
19q, and support for an additional chromosome 1
locus.10 13 14 Although these loci have been mapped,
the causative gene remains to be determined.
A number of candidate genes for PCD with
Abbreviations: ACBT, active cycle of breathing technique;
CF, cystic fibrosis; NCG, National Commissioning Group;
NO, nitric oxide; OME, otitis media with effusion; PCD,
primary ciliary dyskinesia; PEP, positive expiratory pressure
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suggestive roles in ciliogenesis have been selected for mutation
screening in PCD patients but excluded from playing a role in
the disease.9
Certain features of PCD such as situs inversus may be
observed in other disorders that are more closely associated
with dysfunction of the non-motile or sensory cilia. Sensory
cilia are more ubiquitous than motile cilia, being found in most
tissues of the body including in the kidney, retina and
embryonic node, and their dysfunction results in a broad range
of phenotypes including renal and retinal problems.4 This
putative connection is currently clearest for retinal function,
since several cases are known of individuals who have features
consistent with PCD in addition to retinitis pigmentosa or to
Usher syndrome.8 15 Mutations in the X-linked retinitis pig-
mentosa GTPase regulator gene (RPGR) gene have recently
been identified in two brothers with PCD and retinitis
pigmentosa,15 and there are a number of other RPGR
mutations.8
WHEN TO SUSPECT THE DIAGNOSIS OF PCD
PCD may be suspected because of respiratory disease or mirror
image arrangement (conventional diagnostic clues) or because
a non-respiratory condition such as biliary atresia has been
diagnosed (associated diagnosis).
Diagnosis is frequently made late,2 in part because it presents
with symptoms (rhinitis, secretory otitis media, cough) which
are common in children.16 General paediatricians must be alert
to the condition and take a careful, focussed history. Although
there is no proven evidence that early diagnosis is beneficial, in
one series, bronchiectasis at diagnosis was only seen in those
diagnosed over 4 years of age,2 and in a second series, lung
function at diagnosis was significantly worse in those
diagnosed in adult life.5 This is at least supportive evidence
that early diagnosis is beneficial.
There are no data to weight the significance of particular
symptoms or construct receiver operating curves, but the
common diagnostic features of PCD are listed in table 1 as a




Heterotaxy (usually mirror image organ arrangement) on
antenatal ultrasound scanning should lead to consideration of
the diagnosis, although most babies with mirror image
arrangement do not have PCD.
Presentation in the newborn period
N Continuous rhinorrhoea from the first day of life; this is
highly likely to be due to PCD
N Respiratory distress or neonatal pneumonia with no obvious
predisposing cause
N Mirror image arrangement (but see ‘‘Antenatal presenta-
tion’’ above)
N Diagnosis by screening because of a positive family history
Presentation in childhood
N Chronic productive or ‘‘wet’’ cough. Clearly, other causes
such as cystic fibrosis (CF) will likely need to be ruled out
first by appropriate testing, before referral for ciliary
function, unless the child also has mirror image arrange-
ment or other features suggestive of PCD. Isolated dry cough
is not likely to be due to PCD.
N Atypical ‘‘asthma’’, non-responsive to treatment, especially if
a wet-sounding cough is present
N ‘‘Idiopathic’’ bronchiectasis. Diagnosis of bronchiectasis by
screening because of a positive family history of PCD. This
accounted for 10% of cases in one series.2
N Rhinosinusitis. Daily rhinitis is typical, without remission,
and sometimes in older children severe sinusitis despite
multiple surgical procedures; nasal polyps are rare, and more
commonly due to CF.
N Otitis media with effusion (OME). Typically, if tympanost-
omy (ventilation tubes) are inserted, there is usually a
prolonged smelly ear discharge for weeks not responding to
treatment and with no improvement in hearing.
Presentation in adolescence and adult l i fe
N As above, for childhood
N Ectopic pregnancy and subfertility in women6 17
N Male infertility (immotile sperm, but 50% of PCD males are
fertile,18 see below)
PCD as an associated diagnosis
In addition to the above, PCD should be at least considered
when the following diagnoses are made, in particular if there is
a family history of more than one of these conditions, or if the
patient has other features of PCD.3 4
N Complex congenital heart disease, especially with disorders
of laterality19
N Polycystic kidney and liver disease
N Hydrocephalus
N Biliary atresia
N Severe oesophageal disease (oesophageal atresia, severe
reflux)19
N Retinal degeneration, including retinitis pigmentosa
Figure 1 Schematic diagram of the basic
structure of cilia.
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MAKING THE DIAGNOSIS
Eliminating other conditions
Although a child with absolutely typical features of PCD will
appropriately be referred directly for ciliary function studies, in
most cases testing for commoner conditions which enter the
differential diagnosis will precede referral. The nature of the
tests carried out will be determined by the individual clinical
scenario.
Screening for PCD
The most popular screening tests for PCD are the saccharin test
and the measurement of nasal nitric oxide (NO). The saccharin
test involves placing a microtablet of saccharin on the inferior
turbinate and recording the time taken for the subject to taste
it. It is difficult to perform and can be unreliable in children.20
An abnormal result must be confirmed by further tests (see
below). In PCD nasal and exhaled NO is low21 22 for reasons that
are still unclear and measurement of nasal NO, which is more
discriminatory than exhaled NO, is a good screening test.23
However, as there is occasional overlap with other respiratory
conditions such as CF, confirmation of the diagnosis of PCD
will always require further testing.1 6 24
Diagnostic testing
A combined approach to the diagnostic testing of suspected
PCD reduces the number of cases that are incorrectly
diagnosed. Tests include:
N ciliary beat frequency measurement,
N ciliary beat pattern analysis,
N electron microscopy of ciliary ultrastructure,
N measurement of ciliary disorientation, and
N in difficult cases, cell culture with re-growth of the ciliated
epithelium.
Strips of ciliated usually nasal epithelium obtained by
brushing the nose are used to assess ciliary structure and
function. The nasal brushing is an out-patient procedure which
only takes a few seconds. The brushing causes minor
discomfort, and very occasionally, minor epistaxis. The sample
may be taken by an appropriately trained paediatrician in a
general hospital, and sent by courier to the NCG centre, by prior
arrangement. Assessment of beat pattern by slow motion
analysis using high-speed video photography in conjunction
with beat frequency measurements has been shown to identify
defects that may have been missed by analysis of beat
frequency alone.25 An extensive range of normal values for
children and adults using high-speed video analysis has now
been published.26
Some groups have diagnosed PCD in patients who had
clinical symptoms consistent with PCD and a slow ciliary beat
frequency despite a normal ciliary ultrastructure.27 It is still to
be determined whether such patients have an inherited defect
affecting function that cannot be seen on electron microscopy.
While such patients receive clinical treatment similar to that for
PCD, they cannot be confidently diagnosed as having PCD.
Examination of ciliary ultrastructure remains the definitive
test for PCD. There are a number of ultrastructural phenotypes
that can cause PCD.28 Most cases of PCD are due to a lack of
outer dynein arms or a combined lack of both inner and outer
dynein arms. Other defects include isolated lack of inner dynein
arms or lack of inner dynein arms combined with a radial spoke
defect. Rarer defects include those of the central microtubular
pair, such as transposition or central microtubular agenesis.29
On occasions the diagnosis of PCD may be difficult due to
damage to the respiratory epithelium secondary to infection or
inflammation. If secondary damage is still present making the
diagnosis difficult or if the patient is suspected of having an
unusual PCD phenotype, ciliated cells are cultured. Secondary
damage is virtually absent after ciliogenesis in a suspension
culture.30 This technique is only necessary in cases of doubt and
is not mandatory for the diagnosis of clear-cut cases of PCD.
Overall, around 10% of initial tests are equivocal. A second
brushing reduces the figure to 5% (unpublished data). In the
absence of another gold standard test, it is impossible to
calculate false positive and false negative rates. The most
important cause of false positive tests are post-viral changes,
and if there is any doubt, the tests should be repeated before
confirming the diagnosis.
RESPIRATORY MANAGEMENT
Appropriate medical therapy has been shown to prevent
deterioration in lung function.5 6 The optimal balance of care
between the regional centre and district hospital has not been
determined, and is likely in practice to be driven by geography
and the facilities available locally. If the family live reasonably
near a centre with special expertise in PCD, a shared care
arrangement, analogous to CF clinics, might be appropriate.
They should be looked after only in a setting where multi-
disciplinary review is available. Management is not evidence
based. Respiratory management consists of:
N regular respiratory monitoring,
N airway clearance by combinations of physiotherapy and
physical exercise, and
N aggressive treatment of upper and lower airways infections.
Respiratory monitoring
Recommendations are based on CF clinic practices. In some
centres, specialist PCD clinics which include respiratory, ENT
and general care at the one visit, have been set up. In addition
to general paediatric care, monitoring should include pulse
oximetry and age appropriate lung function tests. Regular
sputum or cough swab cultures should be performed.1 Chest
radiographs are probably relatively insensitive. High resolution
computed tomography of the lungs is used to define the extent
of bronchiectasis but is used only very infrequently to monitor
disease progression.
Medical interventions
PCD lung disease is progressive if not adequately treated, and
early therapeutic interventions result in better symptom
control.31 The common infecting organisms in children are
Haemophilus influenza and Staphylococcus aureus, but Streptococcus
pneumoniae, Pseudomonas aeruginosa and non-tuberculous myco-
bacteria have also been reported, although these are usually a
feature of disease in adults.6 There is no evidence to recommend
or otherwise the use of prophylactic antibiotics. If repeated
Table 1 Features leading to the diagnosis of PCD
Presenting feature
Number (%) of
cases (n = 55)
Significant neonatal respiratory distress 37 (67)
Abnormal situs 38 (69)
Cough most days 46 (84)
Sputum production 24 (44)
Rhinorrhoea from the newborn period 42 (76)
Wheeze 16 (29)
Sinusitis 6 (11)
Serous otitis media 28 (51)
Hearing loss 14 (25)
Diagnosis made in a sibling 6 (11)
Modified from Coren et al.2 Most children had multiple symptoms, typically a
combination of upper and lower airway disease.
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courses of oral antibiotics are required, prophylaxis should be
considered. High-dose oral antibiotics should be given at the
first sign of worsening respiratory symptoms or deterioration in
lung function. Where possible, antibiotics should be chosen on
the basis of sputum or cough swab culture and sensitivity.
Occasionally, broncho-alveolar lavage may be necessary to
obtain adequate specimens in non-sputum producing children.
If P aeruginosa is isolated, most use an eradication regime
similar to CF. For established chronic infection with this
organism, long-term nebulised anti-pseudomonal antibiotics
are considered. If symptoms do not respond to oral antibiotics,
then intravenous therapy is given. A regular programme of 3-
monthly intravenous therapy should be considered in patients
who are not doing well.
Regular bronchodilators are not particularly effective. No
trials have studied any anti-inflammatory therapy. Anecdotally,
many of these patients have previously been misdiagnosed as
having asthma and given asthma therapy, which is ineffective.
It is very important to be proactive in discontinuing medica-
tions which have been started in error and which are not
effective. The use of rhDNAse is unproven; anecdotally some
patients show an improvement. Nebulised saline may be
effective in augmenting mucus clearance.
PCD patients should receive all childhood immunisations,
including influenza A and pneumococcal. Complications of
bronchiectasis and chronic lung disease become more promi-
nent with age.6 Lobectomy for bronchiectasis is rarely recom-
mended. A few patients require lung transplantation. Overall,
the medical therapy of PCD is more successful than that for CF;
once treatment is instituted, even if there is markedly impaired
lung function at diagnosis, PCD should be stabilised.5 6
AIRWAY INFLAMMATION
There has been little work on airway inflammation in PCD.
Examination of spontaneously expectorated sputum reveals
predominantly neutrophilic cytology, as in CF.32 Since CF is
characterised by relentless deterioration, and PCD by stability,
one might predict that the inflammatory response would be
greater in CF, but this is not the case; mucus biophysical and
transport properties are the same, and sputum interleukin (IL)-
8 is actually three times higher in PCD.33
PHYSIOTHERAPY
There is no evidence that physiotherapy treatment is beneficial
in PCD and options should be tailored to the individual. The
parents of babies and infants should be shown gravity assisted
positioning and intermittent chest percussion; the optimum
duration and frequency is not known. Jumping and blowing
games should be encouraged early on and replaced by the active
cycle of breathing technique (ACBT) as the child becomes
older.34 Independence is encouraged in older patients.
Alternative techniques include the PEP (positive expiratory
pressure) mask or mouthpiece35 and oscillating PEP devices
such as the Flutter36 or Acapella.37 Adherence to treatment must
also be considered.31
Physical exercise may help sputum clearance. Exercise has
been shown to be a better bronchodilator than the use of a b-2
agonist in PCD.38 Exercise should be encouraged from early on.
The role of inspiratory muscle training in PCD is not known.39
ENT MANAGEMENT
Abnormal mucociliary clearance within the upper airway in
PCD leads to OME and chronic mucus pooling within the nasal
cavity and paranasal sinuses. OME, often severe, is universal
among infants with PCD and resolves spontaneously at around
age 13.40 It presents with either hearing loss and speech delay or
as recurrent acute otitis media. Ventilation tube insertion is
associated with a high level of post-operative mucoid otorrhoea
and tympanic membrane perforation.41 This operation should
be avoided if at all possible, and certainly should not be
performed before consultation with a surgeon familiar with the
management of PCD. The best way to treat otorrhoea is by
cleaning the ear, avoiding water in the ear, and administering
topical non-ototoxic anti-pseudomonal antibiotic eardrops, for
example ciprofloxacin. All children with PCD should have
regular hearing tests at least until adolescence. If necessary,
hearing aids are recommended until spontaneous resolution of
hearing loss. For milder hearing loss, educational support may
be all that is needed. Speech delay should be promptly managed
with speech therapy.
Chronic mucoid rhinorrhoea may be treated using saline
nasal douches. Long-term topical nasal steroids are of uncertain
benefit for rhinorrhoea but will treat any degree of rhinosinu-
sitis. Recurrent acute or chronic sinusitis is rare. It may be
managed with prolonged systemic antibiotics but occasionally
requires endoscopic sinus surgery. Nasal polyps are virtually
never seen. Obstructive sleep apnoea secondary to adeno-
tonsillar hypertrophy is also not a typical association with PCD.
OTHER SYSTEMS
Around half of the men who have PCD are infertile, although
many men have fathered children with no medical interven-
tion.18 Infertility in men with PCD is entirely attributed to the
poor motility of the sperm. There are several reports of the birth
of healthy children after intracytoplasmic sperm injection.
Females have reduced fertility with higher risk for ectopic
pregnancy.17 Rarer associations of PCD are described above. The
management of these associated conditions is unaffected by
coincident PCD, except in so far as respiratory issues must be
remembered if a general anaesthetic is required.
NURSING PERSPECTIVE
Very little has been published on the role of the paediatric nurse
specialist in the care of children with PCD, and the models of
care have to be based on the CF nurse specialist. The nurse
should be involved in pretest counselling. After diagnosis, the
psychological and practical support provided by the respiratory
nurse includes clinical management, education, social care and
counselling.42 The nurse specialist is ideally placed to become
the key worker, providing a link between hospital, home, the
school and primary care.43 Children with PCD must be
encouraged to lead a normal life and should be encouraged to
participate in all usual activities at home and school including
sport.
SUMMARY AND CONCLUSIONS
Ciliopathy has now become recognised as a multisystem
disease, of which PCD is an important subgroup. The current
challenge for paediatricians is to increase diagnostic awareness,
and make early and appropriate referrals to the new diagnostic
services before the child has sustained lung damage. Next, we
need to find ways through multicentre collaborations of
increasing the evidence base for treatment. In the future, basic
science may open the way for curative treatment, as opposed to
mere management of symptoms. However, none of this will
happen unless as a routine, a properly focused respiratory
history is taken, and the diagnosis of PCD considered outside
the context of specialist clinics.
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